Scot-Tussin Original (old formulation) Drug Interactions
Currently displaying 51 drugs known to have a major interaction with Scot-Tussin Original (old formulation) (caffeine / pheniramine / phenylephrine / sodium citrate / sodium salicylate).
- 51 major drug interactions
- 592 moderate drug interactions
- 49 minor drug interactions
Major interactions with Scot-Tussin Original (old formulation) (caffeine / pheniramine / phenylephrine / sodium citrate / sodium salicylate)
Note: Showing generic names only.
- deferasirox
- desipramine
- dichlorphenamide
- dihydroergotamine
- dihydroxyaluminum sodium carbonate
- dorzolamide ophthalmic
- doxepin
- imipramine
- influenza virus vaccine, h1n1, live
- influenza virus vaccine, live
- iobenguane I 131
- isocarboxazid
Scot-Tussin Original (old formulation) alcohol/food interactions
There are 6 alcohol/food interactions with Scot-Tussin Original (old formulation) (caffeine / pheniramine / phenylephrine / sodium citrate / sodium salicylate).
Scot-Tussin Original (old formulation) disease interactions
There are 30 disease interactions with Scot-Tussin Original (old formulation) (caffeine / pheniramine / phenylephrine / sodium citrate / sodium salicylate) which include:
- sodium/water balance
- cardiac disease
- hypertension
- psychiatric disorders
- inflammatory bowel disease
- intestinal obstruction disorders
- PUD
- GI toxicity
- renal dysfunction
- Reye's syndrome
- cardiovascular disease
- acid/base balance
- anticholinergic effects
- asthma/COPD
- cardiovascular
- renal/liver disease
- cardiotoxicity
- liver disease
- renal dysfunction
- seizure disorders
- GERD
- anemia
- coagulation
- dialysis
- G-6-PD deficiency
- hepatotoxicity
- sodium
- BPH
- diabetes
- glaucoma
Drug Interaction Classification
Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.